【正文】
細(xì)胞因子( SCF) 骨髓衰竭 TGFβ 炎癥 IL11 血小板減少癥 IL1受體拮抗劑 敗血性休克,類風(fēng)濕關(guān)節(jié)炎 PLXY321 骨髓衰竭 已批準(zhǔn)臨床試驗的細(xì)胞因子多肽藥物 Autoreactive T cell Synovial fibroblast M? IFN?, IL17 IL1, IL15 IL1, TNF? Chondrocyte Osteoclast MMPs, IL6, IL8, GMCSF Cartilage and bone destruction TNF inhibitors IL1 inhibitor IL6 inhibitor Oral tolerance T cell vaccine MMPs T cell costimulatory blockers Archivum Immunologiae et Therapiae Experimentalis (AITE), 2022, 58: 2736 Target Name of therapeutic Product of description Stage of development Current TNF? Etanercept Soluble p75 TNFR–human IgG1Fc fusion protein Lisenced Infliximab Chimeric mAb specific for TNF? Lisenced Adalimumab Humanized mAb specific for TNFα Lisenced IL1 Anakinra IL1ra Lisenced IL6 Tocilizumab Humanized mAb specific for IL6R Phase III clinical trials In perspective IL1 AMG 108 Humanized mAb specific for IL1β Phase II clinical trials IL15 HuMaxIL15 (AMG 714) HuMax IL15 (AMG 714) Phase II clinical trials IL17 Lubberts E (2022) IL21 Andersson AK et al (2022) Biological therapeutics that target inflammatory cytokines in RA 細(xì)胞因子基因療法 臨床治療的思考? ?轉(zhuǎn)何種細(xì)胞因子或趨化因子基因? ?轉(zhuǎn)到什么細(xì)胞? 細(xì)胞因子模擬肽 利用已知細(xì)胞因子的受體從肽庫內(nèi)篩選細(xì)胞因子模擬肽,近年成為國內(nèi)外研究的熱點。國外已篩選到了人促紅細(xì)胞生成素,人促血小板生成素,人生長激素、人神經(jīng)生長因子及白細(xì)胞介素 1等多種生長因子的模擬肽 , 這些模擬肽的氨基酸序列與其相應(yīng)的細(xì)胞因子的氨基酸序列不同,但具有細(xì)胞因子的活性,并且具有分子量小的優(yōu)點。這些細(xì)胞因子模擬肽正處于臨床前或臨床研究階段。